The latest study on Clinical Oncology Next Generation Sequencing (NGS) Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Clinical Oncology Next Generation Sequencing (NGS) Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Clinical Oncology Next Generation Sequencing (NGS) and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Macrogen
Perkin Elmer
Myriad Genetics
Oxford Nanopore Technologies
Qiagen
Caris Life Sciences
GATC Biotech
BGI
Paradigm
Genomatix Software
CLC Bio
Foundation Medicine
Knome
Biomatters
GnuBIO
Agilent Technologies
Exosome Diagnostics
Partek
Roche
DNASTAR
Pacific Bioscience
Illumina
Life Technologies
Clinical Oncology Next Generation Sequencing (NGS) Market Analysis By Type Segment:
NGS Pre-Sequencing
Sequencing
NGS Data Analysis
Primary, Secondary & Tertiary Data Analysis
Clinical Oncology Next Generation Sequencing (NGS) Market Analysis By Application Segment:
Academic & Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
The Clinical Oncology Next Generation Sequencing (NGS) Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Clinical Oncology Next Generation Sequencing (NGS) Report:
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Clinical Oncology Next Generation Sequencing (NGS) Market:
Clinical Oncology Next Generation Sequencing (NGS) market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
Detailed information about Key Top Competitors in the Global Clinical Oncology Next Generation Sequencing (NGS) Market
What is the expected Market size and growth rate of the Clinical Oncology Next Generation Sequencing (NGS) market for the forecast period
Where is the largest and fastest growing market for Clinical Oncology Next Generation Sequencing (NGS) market
How does the market relate to the overall economy, demography and other similar markets
What forces will shape the market going forward
Can I include additional segmentation / market segmentation
Clinical Oncology Next Generation Sequencing (NGS) market global report answers all these questions and many more.
The study objectives are:
To analyze and research the Clinical Oncology Next Generation Sequencing (NGS) Market status and future forecast.
To present the key Clinical Oncology Next Generation Sequencing (NGS) Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Frequently Asked Questions - FAQ:
How big is the opportunity for the Clinical Oncology Next Generation Sequencing (NGS) market
Which are the recent industry development that can be implemented to generate additional revenue streams
Who are the major players operating in the Clinical Oncology Next Generation Sequencing (NGS) market Which companies are the front runners
What are the major end-use industries of Clinical Oncology Next Generation Sequencing (NGS) market
Feel free to contact us for Customisation, Request For Free Sample, Ask for discount
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate by Type (2016-2027)
1.4.2 NGS Pre-Sequencing
1.4.3 Sequencing
1.4.4 NGS Data Analysis
1.4.5 Primary, Secondary & Tertiary Data Analysis
1.5 Market by Application
1.5.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2016-2027)
1.5.2 Academic & Clinical Research
1.5.3 Hospitals & Clinics
1.5.4 Pharma & Biotech Entities
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size
2.2 Clinical Oncology Next Generation Sequencing (NGS) Growth Trends by Regions
2.2.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions (2016-2027)
2.2.2 Clinical Oncology Next Generation Sequencing (NGS) Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size by Manufacturers
3.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Manufacturers (2016-2020)
3.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Manufacturers (2016-2020)
3.1.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Concentration Ratio (CR5 and HHI)
3.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players Head office and Area Served
3.3 Key Players Clinical Oncology Next Generation Sequencing (NGS) Product/Solution/Service
3.4 Date of Enter into Clinical Oncology Next Generation Sequencing (NGS) Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2016-2020)
4.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2016-2020)
5 United States
5.1 United States Clinical Oncology Next Generation Sequencing (NGS) Market Size (2016-2020)
5.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in United States
5.3 United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
5.4 United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
6 Europe
6.1 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size (2016-2020)
6.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in Europe
6.3 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
6.4 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
7 China
7.1 China Clinical Oncology Next Generation Sequencing (NGS) Market Size (2016-2020)
7.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in China
7.3 China Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
7.4 China Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
8 Japan
8.1 Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size (2016-2020)
8.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in Japan
8.3 Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
8.4 Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size (2016-2020)
9.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in Southeast Asia
9.3 Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
9.4 Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
10 India
10.1 India Clinical Oncology Next Generation Sequencing (NGS) Market Size (2016-2020)
10.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in India
10.3 India Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
10.4 India Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
11 Central & South America
11.1 Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size (2016-2020)
11.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in Central & South America
11.3 Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
11.4 Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
12 International Players Profiles
12.1 Illumina
12.1.1 Illumina Company Details
12.1.2 Company Description and Business Overview
12.1.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.1.4 Illumina Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)
12.1.5 Illumina Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.2.4 Roche Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)
12.2.5 Roche Recent Development
12.3 Agilent Technologies
12.3.1 Agilent Technologies Company Details
12.3.2 Company Description and Business Overview
12.3.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.3.4 Agilent Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)
12.3.5 Agilent Technologies Recent Development
12.4 Knome
12.4.1 Knome Company Details
12.4.2 Company Description and Business Overview
12.4.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.4.4 Knome Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)
12.4.5 Knome Recent Development
12.5 Genomatix Software
12.5.1 Genomatix Software Company Details
12.5.2 Company Description and Business Overview
12.5.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.5.4 Genomatix Software Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)
12.5.5 Genomatix Software Recent Development
12.6 GATC Biotech
12.6.1 GATC Biotech Company Details
12.6.2 Company Description and Business Overview
12.6.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.6.4 GATC Biotech Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)
12.6.5 GATC Biotech Recent Development
12.7 Oxford Nanopore Technologies
12.7.1 Oxford Nanopore Technologies Company Details
12.7.2 Company Description and Business Overview
12.7.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.7.4 Oxford Nanopore Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)
12.7.5 Oxford Nanopore Technologies Recent Development
12.8 Macrogen
12.8.1 Macrogen Company Details
12.8.2 Company Description and Business Overview
12.8.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.8.4 Macrogen Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)
12.8.5 Macrogen Recent Development
12.9 Life Technologies
12.9.1 Life Technologies Company Details
12.9.2 Company Description and Business Overview
12.9.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.9.4 Life Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)
12.9.5 Life Technologies Recent Development
12.10 DNASTAR
12.10.1 DNASTAR Company Details
12.10.2 Company Description and Business Overview
12.10.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.10.4 DNASTAR Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)
12.10.5 DNASTAR Recent Development
12.11 Exosome Diagnostics
12.12 Biomatters
12.13 CLC Bio
12.14 BGI
12.15 Qiagen
12.16 Perkin Elmer
12.17 Pacific Bioscience
12.18 Partek
12.19 GnuBIO
12.20 Foundation Medicine
12.21 Paradigm
12.22 Caris Life Sciences
12.23 Myriad Genetics
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
List of Tables and Figures
List of Tables and Figures
Table Clinical Oncology Next Generation Sequencing (NGS) Key Market Segments
Table Key Players Clinical Oncology Next Generation Sequencing (NGS) Covered
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type 2016-2027
Figure NGS Pre-Sequencing Figures
Table Key Players of NGS Pre-Sequencing
Figure Sequencing Figures
Table Key Players of Sequencing
Figure NGS Data Analysis Figures
Table Key Players of NGS Data Analysis
Figure Primary, Secondary & Tertiary Data Analysis Figures
Table Key Players of Primary, Secondary & Tertiary Data Analysis
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth by Application 2016-2027 (Million US$)
Figure Academic & Clinical Research Case Studies
Figure Hospitals & Clinics Case Studies
Figure Pharma & Biotech Entities Case Studies
Figure Clinical Oncology Next Generation Sequencing (NGS) Report Years Considered
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size 2016-2027 (Million US$)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions 2016-2027 (Million US$)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions 2016-2020 (Million US$)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Regions 2016-2020
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Regions 2016-2020
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Regions 2020
Table Market Top Trends
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Manufacturers (2016-2020) (Million US$)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Manufacturers (2016-2020)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Manufacturers in 2020
Table Global Clinical Oncology Next Generation Sequencing (NGS) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Clinical Oncology Next Generation Sequencing (NGS) Product/Solution/Service
Table Date of Enter into Clinical Oncology Next Generation Sequencing (NGS) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2016-2020) (Million US$)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Share by Type (2016-2020)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2016-2020)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2016-2020) (Million US$)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Share by Application (2016-2020)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2016-2020)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Application in 2020
Figure United States Clinical Oncology Next Generation Sequencing (NGS) Market Size 2016-2020 (Million US$)
Table United States Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2020-2020) (Million US$)
Table United States Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2020-2020)
Table United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2016-2020) (Million US$)
Table United States Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2016-2020)
Table United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2016-2020) (Million US$)
Table United States Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2016-2020)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size 2016-2020 (Million US$)
Table Europe Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2020-2020) (Million US$)
Table Europe Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2020-2020)
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2016-2020) (Million US$)
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2016-2020)
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2016-2020) (Million US$)
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2016-2020)
Figure China Clinical Oncology Next Generation Sequencing (NGS) Market Size 2016-2020 (Million US$)
Table China Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2020-2020) (Million US$)
Table China Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2020-2020)
Table China Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2016-2020) (Million US$)
Table China Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2016-2020)
Table China Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2016-2020) (Million US$)
Table China Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2016-2020)
Figure Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size 2016-2020 (Million US$)
Table Japan Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2020-2020) (Million US$)
Table Japan Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2020-2020)
Table Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2016-2020) (Million US$)
Table Japan Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2016-2020)
Table Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2016-2020) (Million US$)
Table Japan Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2016-2020)
Figure Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2020-2020) (Million US$)
Table Southeast Asia Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2020-2020)
Table Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2016-2020)
Table Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2016-2020)
Figure India Clinical Oncology Next Generation Sequencing (NGS) Market Size 2016-2020 (Million US$)
Table India Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2020-2020) (Million US$)
Table India Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2020-2020)
Table India Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2016-2020) (Million US$)
Table India Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2016-2020)
Table India Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2016-2020) (Million US$)
Table India Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2016-2020)
Figure Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2020-2020) (Million US$)
Table Central & South America Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2020-2020)
Table Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2016-2020) (Million US$)
Table Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2016-2020)
Table Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2016-2020) (Million US$)
Table Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2016-2020)
Table Illumina Company Details
Table Illumina Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020) (Million US$)
Figure Illumina Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)
Table Illumina Recent Development
Table Roche Company Details
Table Roche Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)(Million US$)
Figure Roche Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)
Table Roche Recent Development
Table Agilent Technologies Company Details
Table Agilent Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)(Million US$)
Figure Agilent Technologies Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)
Table Agilent Technologies Recent Development
Table Knome Company Details
Table Knome Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)(Million US$)
Figure Knome Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)
Table Knome Recent Development
Table Genomatix Software Company Details
Table Genomatix Software Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)(Million US$)
Figure Genomatix Software Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)
Table Genomatix Software Recent Development
Table GATC Biotech Company Details
Table GATC Biotech Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)(Million US$)
Figure GATC Biotech Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)
Table GATC Biotech Recent Development
Table Oxford Nanopore Technologies Company Details
Table Oxford Nanopore Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)(Million US$)
Figure Oxford Nanopore Technologies Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)
Table Oxford Nanopore Technologies Recent Development
Table Macrogen Company Details
Table Macrogen Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)(Million US$)
Figure Macrogen Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)
Table Macrogen Recent Development
Table Life Technologies Company Details
Table Life Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)(Million US$)
Figure Life Technologies Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)
Table Life Technologies Recent Development
Table DNASTAR Company Details
Table DNASTAR Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)(Million US$)
Figure DNASTAR Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2016-2020)
Table DNASTAR Recent Development
Table Exosome Diagnostics Company Details
Table Biomatters Company Details
Table CLC Bio Company Details
Table BGI Company Details
Table Qiagen Company Details
Table Perkin Elmer Company Details
Table Pacific Bioscience Company Details
Table Partek Company Details
Table GnuBIO Company Details
Table Foundation Medicine Company Details
Table Paradigm Company Details
Table Caris Life Sciences Company Details
Table Myriad Genetics Company Details
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions (Million US$) 2021-2027
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Share by Regions (2021-2027)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Share by Regions in 2027
Figure United States Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2021-2027)(Million USD)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2021-2027)(Million USD)
Figure China Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2021-2027)(Million USD)
Figure Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2021-2027)(Million USD)
Figure India Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2021-2027)(Million USD)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Product (2021-2027) (Million US$)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Product (2021-2027)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Product in 2027
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2021-2027) (Million US$)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2021-2027)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources